Contact
Please use this form to send email to PR contact of this press release:
Aurigene to Present Multiple Programs at the AACR 2018 In Chicago, Illinois: (A) Novel Small Molecule, Oral, Antagonists of CD47-SIRPα Interaction; (B) Novel PRMT5 Inhibitors; (C) Covalent, Selective CDK12 Inhibitors and (D) SMARCA2/4 Degraders
TO: